US equities |
SPCX $166.84 ▲+4.96% NVDA $236.57 ▲+1.12% MU $1,062.54 ▼-1.15% TSLA $376.80 ▲+1.67% MSFT $524.71 ▲+1.39% SNDK $1,702.31 ▼-1.03% INTC $117.31 ▼-1.69% META $742.57 ▲+1.99%
FinancialContent

Articles published by ROBBINS GELLER

News headline image
MLTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From ROBBINS GELLER
Via Business Wire
Tickers MLTX